Comparison
2p13 2 Microdeletion Syndrome C4749460 vs 11q22 2q22 3 Microdeletion Syndrome C5680062
Clinical comparison between 2p13 2 Microdeletion Syndrome and 11q22 2q22 3 Microdeletion Syndrome for differential diagnosis and treatment planning.
2p13 2 Microdeletion Syndrome C4749460
A rare chromosomal condition where a small segment is missing from chromosome 2. Features vary based on which genes are affected. Care focuses on addressing specific symptoms.
11q22 2q22 3 Microdeletion Syndrome C5680062
A rare genetic condition where a small segment of chromosome 11 is missing. It can affect development and cause various health concerns. Treatment focuses on managing specific symptoms with supportive care.
6 comparison axes
Onset
2p13 2 Microdeletion Syndrome C4749460
0-0
11q22 2q22 3 Microdeletion Syndrome C5680062
0-null
Onset patterns differ
Severity
2p13 2 Microdeletion Syndrome C4749460
severe
11q22 2q22 3 Microdeletion Syndrome C5680062
moderate
Different severity levels
Chronic
2p13 2 Microdeletion Syndrome C4749460
Chronic
11q22 2q22 3 Microdeletion Syndrome C5680062
Chronic
Differing course
Communicable
2p13 2 Microdeletion Syndrome C4749460
No
11q22 2q22 3 Microdeletion Syndrome C5680062
No
Different transmission
Body System
2p13 2 Microdeletion Syndrome C4749460
congenital
11q22 2q22 3 Microdeletion Syndrome C5680062
congenital
Same/different system
Category
2p13 2 Microdeletion Syndrome C4749460
rare-disease
11q22 2q22 3 Microdeletion Syndrome C5680062
genetic
Different category
Bottom line
2p13-2-microdeletion-syndrome-C4749460 and 11q22-2q22-3-microdeletion-syndrome-C5680062 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 2p13 2 Microdeletion Syndrome C4749460 | 11q22 2q22 3 Microdeletion Syndrome C5680062 | Discriminating power |
|---|---|---|---|
| Developmental or congenital features | Features may occur but vary with the missing genes; no definitive pattern is established here. | Development and other health concerns may occur, with variable features. | Low |
| Overall clinical severity | Classified as severe in the supplied data, without a specified complication profile. | Classified as moderate, although individual severity can vary. | Moderate |
| Age at recognition | Onset is recorded as congenital, from birth. | Onset is incompletely specified and should not be assumed. | Moderate |
When to favor each condition
Choose 2p13 2 Microdeletion Syndrome C4749460 when
A confirmed deletion involves 2p13.2
The chromosomal location, not symptoms alone, distinguishes this condition.
High
A severe congenital presentation needs syndrome-specific counseling
The supplied classification is severe, but phenotype details remain limited.
Moderate
Family history or prior testing points to chromosome 2
Targeted review can confirm whether the reported region is involved.
Moderate
Choose 11q22 2q22 3 Microdeletion Syndrome C5680062 when
A confirmed deletion involves 11q22.2-q22.3
Genomic location is the principal discriminator supplied here.
High
Developmental concerns occur with a moderate classification
This matches the supplied severity, but does not prove the diagnosis.
Low
Chromosome 11 testing is already suggestive
Confirmation should define breakpoints before syndrome assignment.
Moderate
How key tests differ
| Test | 2p13 2 Microdeletion Syndrome C4749460 | 11q22 2q22 3 Microdeletion Syndrome C5680062 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | May identify a copy-number loss at 2p13.2. | May identify a copy-number loss at 11q22.2-q22.3. | Location and gene content require laboratory and clinical correlation. |
| Karyotype | May be normal if the deletion is below its resolution. | May also miss a small deletion. | A normal karyotype does not exclude either microdeletion. |
| Targeted confirmation such as FISH or sequencing-based copy-number analysis | Can support a 2p13.2 finding when appropriately designed. | Can support an 11q22.2-q22.3 finding when appropriately designed. | Test choice depends on the laboratory and suspected region. |
Prognosis comparison
2p13 2 Microdeletion Syndrome C4749460
- Outcome
- Long-term outcome is not established; the supplied severity is severe.
- Factors
- Affected genes, deletion extent, and individual complications may influence outlook.
11q22 2q22 3 Microdeletion Syndrome C5680062
- Outcome
- Long-term outcome is not established; the supplied severity is moderate.
- Factors
- Developmental and health findings, deletion extent, and available support may influence outlook.
Time frame: Both are described as chronic, with no reliable timeline supplied.
Prognosis should be individualized; mortality and prevalence are not established here.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental needs | Possible but not specifically characterized here. Development may be affected, with details not established. Assessment should be individualized rather than inferred from the label. |
| Organ or health problems | May depend on which genes are missing. Various health concerns are possible but unspecified. No definitive complication list is supported by the supplied data. |
| Long-term care burden | Potentially substantial given the severe classification. May be significant but is classified as moderate. Actual burden varies and is not predictable from these data alone. |
Patient education highlights
- HighDiagnosis
A reported microdeletion requires confirmation of the exact chromosomal region and clinical interpretation.
- HighVariable features
Neither condition has a complete symptom list in the supplied information; findings can differ between people.
- MediumCare
Care is supportive and directed at identified needs; no treatment dose or specific therapy is established here.